KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity (2016 - 2025)

Historic Return on Equity for Sarepta Therapeutics (SRPT) over the last 14 years, with Q3 2025 value amounting to 0.27%.

  • Sarepta Therapeutics' Return on Equity rose 1600.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.2% for FY2024, which is 10600.0% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Return on Equity stood at 0.27% for Q3 2025, which was up 1600.0% from 0.31% recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Return on Equity high stood at 0.31% for Q2 2025, and its period low was 2.03% during Q1 2023.
  • Its 5-year average for Return on Equity is 0.62%, with a median of 0.64% in 2022.
  • Per our database at Business Quant, Sarepta Therapeutics' Return on Equity tumbled by -16300bps in 2023 and then skyrocketed by 20500bps in 2024.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Return on Equity stood at 0.6% in 2021, then plummeted by -188bps to 1.73% in 2022, then surged by 62bps to 0.66% in 2023, then surged by 126bps to 0.17% in 2024, then skyrocketed by 55bps to 0.27% in 2025.
  • Its Return on Equity was 0.27% in Q3 2025, compared to 0.31% in Q2 2025 and 0.15% in Q1 2025.